DecisionView
, a provider of software solutions to optimize clinical trial enrollment for life sciences companies, is pleased to announce that Pfizer has won a
CIO 100 award
based on their successful deployment of DecisionView StudyOptimizer. StudyOptimizer is a web-based patient enrollment optimization solution that automates the planning and tracking of patient enrollment for global clinical trials. It leverages predictive modeling to forecast enrollment end dates during planning, throughout execution and for modeling recovery scenarios when enrollment goes off track.
Pfizer Clinical Trial Enrollment Optimization
The CIO 100 2010 Winner Profile describes Pfizer's clinical trial enrollment optimization project this way:
"To help complete their clinical trials on time and on budget, Pfizer deployed DecisionView's StudyOptimizer, enabling clinical teams to optimize enrollment in trials using predictive modeling and visualization. The Software-as-a-Service (SaaS)-based system allows users to analyze current data, forecast trial end-dates, and track the impact of possible course changes. Among its benefits, the system has reduced the time it takes to enroll patients by 30 to 40 days, saving $4 million annually."
CIO 100 Award Criteria
The 2010 CIO 100 Awards, sponsored by CIO magazine, honor 100 companies that are creating new business value by innovating with technology. The judges evaluated the applications according to two criteria: innovation and business value. CIO 100 winners had to demonstrate that they not only were able to create new value using IT and executed their project well, but also did so in uncommon, innovative ways:
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.